Iron alters Ca2+ homeostasis in doxorubicin-resistant K562 cells

被引:2
|
作者
Yalcintepe, Leman [1 ]
Erdag, Demet [1 ]
Akbas, Fahri [2 ]
Kucukkaya, Bahire [3 ]
机构
[1] Istanbul Univ, Istanbul Fac Med, Dept Biophys, Istanbul, Turkey
[2] Bezmialem Vakif Univ, Fac Med, Dept Med Biol, Istanbul, Turkey
[3] Istanbul Yeni Yuzyil Univ, Fac Med, Dept Biophys, Istanbul, Turkey
关键词
doxorubicin; drug resistance; intracellular calcium; iron; INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR; MULTIDRUG-RESISTANCE; INTRACELLULAR CALCIUM; MOLECULAR-MECHANISMS; NA+/CA2+ EXCHANGERS; THERAPY RESISTANCE; P-GLYCOPROTEIN; CANCER; SENSITIVITY; METABOLISM;
D O I
10.1111/1440-1681.13295
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Iron is an essential trace element especially in cell proliferation, and growth for various cellular events. An increasing amount of research has shown that iron metabolism is altered in tumour cells which usually have rapid growth rates. However, the number of studies on iron metabolism, and calcium regulation are limited in drug-resistant tumour cells. Previously, we have shown that modulation of iron metabolism through iron chelation regulated the intracellular calcium, and increased the doxorubicin sensitivity. In the present study, we investigated the effects of iron on mRNA expression profiles of fifteen key genes (IP(3)R1/2/3, RYR1/2, SERCA1/2/3, NCX1/2/3, PMCA1/2/3, and PMCA4) related to calcium homeostasis in the parental cell line K562 and its subclone doxorubicin-resistant K562 cells. According to the Delta Delta Ct method with a two-fold expression difference (P < .05) as a cut-off level, although iron showed differential effects on most of the genes, IP3R and PMCA genes were especially determined to have changed significantly. These results show that iron metabolism is an important metabolism due to changes in the expression of genes involved in calcium regulation and is a new perspective to overcome cancer/drug resistance.
引用
收藏
页码:1221 / 1230
页数:10
相关论文
共 50 条
  • [21] In vitro cellular accumulation and cytotoxicity of liposomal and conventional formulations of daunorubicin and doxorubicin in resistant K562 cells
    Wang, YY
    Eksborg, S
    Lewensohn, R
    Lindberg, A
    Liliemark, E
    ANTI-CANCER DRUGS, 1999, 10 (10) : 921 - 928
  • [22] Transport mechanisms of anthracycline derivatives in human leukemia cell lines: Uptake of pirarubicin, daunorubicin and doxorubicin by K562 and multidrug-resistant K562/ADM cells
    Nagasawa, K
    Takara, K
    Nomiyama, M
    Ohnishi, N
    Yokoyama, T
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 1996, 19 (07) : 971 - 976
  • [23] Interaction of CJZ3, a lomerizine derivative, with ATPase activity of human P-glycoprotein in doxorubicin-resistant human myelogenous leukemia (K562/DOX) cells
    Ji, Bian-Sheng
    Li, Ming
    He, Ling
    PHARMAZIE, 2010, 65 (07): : 515 - 519
  • [24] Sensitization of K562 Leukemia Cells to Doxorubicin by the Viscum album Extract
    Srdic-Rajic, Tatjana
    Tisma-Miletic, Nevena
    Cavic, Milena
    Kanjer, Ksenija
    Savikin, Katarina
    Galun, Danijel
    Konic-Ristic, Aleksandra
    Zoranovic, Tamara
    PHYTOTHERAPY RESEARCH, 2016, 30 (03) : 485 - 495
  • [25] Reversal of p-glycoprotein-mediated multidrug resistance by CJX1, an amlodipine derivative, in doxorubicin-resistant human myelogenous leukemia (K562/DOX) cells
    Ji, BS
    He, L
    Liu, GQ
    LIFE SCIENCES, 2005, 77 (18) : 2221 - 2232
  • [26] Reversal of multidrug resistance by 5,5′-dimethoxylariciresinol-4-O-β-D-glucoside in doxorubicin-resistant human leukemia K562/DOX cells
    Wang, Tian-Xiao
    Shi, Xiao-Yan
    Cong, Yue
    Wang, Shi-Guang
    Wang, Ying-Ying
    Zhang, Zhong-Qin
    INDIAN JOURNAL OF PHARMACOLOGY, 2013, 45 (06) : 597 - 602
  • [27] 6′-Hydroxy Justicidin B Triggers a Critical Imbalance in Ca2+ Homeostasis and Mitochondrion-Dependent Cell Death in Human Leukemia K562 Cells
    Luo, Jiaoyang
    Qin, Jiaan
    Fu, Yanwei
    Zhang, Shanshan
    Zhang, Xingguo
    Yang, Meihua
    FRONTIERS IN PHARMACOLOGY, 2018, 9
  • [28] In Vitro Antileukemia Activity of ZSTK474 on K562 and Multidrug Resistant K562/A02 Cells
    Zhou, Qianxiang
    Chen, Yali
    Chen, Xi
    Zhao, Wennan
    Zhong, Yuxu
    Wang, Ran
    Jin, Meihua
    Qiu, Yuling
    Kong, Dexin
    INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2016, 12 (06): : 631 - 638
  • [29] EFFECT OF IRON CHELATORS ON THE TRANSFERRIN RECEPTOR IN K562 CELLS
    BRIDGES, KR
    CUDKOWICZ, A
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1984, 259 (21) : 2970 - 2977
  • [30] COPPERS INFLUENCE ON IRON-METABOLISM IN K562 CELLS
    PERCIVAL, SS
    ARMSTRONG, E
    FASEB JOURNAL, 1991, 5 (05): : A1291 - A1291